Cannabis Clinical Trials

© iStock/Steve Debenport Dr Guy Chamberland explains how Tetra Bio-Pharma is taking a pharmaceutical pathway to discovering and developing cannabinoid-derived products. In an industry that could aptly be described as last year’s biggest newsmaker, it seems that Tetra Bio-Pharma has become inextricably linked to all things cannabis. The irony lies in the fact that Tetra […]

by

ALGAE TEC LTD/S (OTCMKTS:ALGXY) and Incyte (NASDAQ:INCY) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their valuation, dividends, risk, institutional ownership, analyst recommendations, earnings and profitability. Profitability This table compares ALGAE TEC LTD/S and Incyte’s net margins, return on equity and return […]

by

RAMAT GAN, Israel, Feb. 11, 2019 /PRNewswire/ — OWC Pharmaceutical Research Corp. (OTCQB: OWCP), a developer of cannabinoid-based therapies targeting a variety of different medical conditions and disorders, today issued a letter to shareholders. To our Shareholders, The last year was a critical year in which we laid the foundations for the sustainable success for […]

by

I should start by noting that I’ve been part of a cannabis couple for more than ten years. I met my wife Elise McDonough while we were both working at High Times magazine. She’s now Leafly’s NorCal Product Specialist, author of the recently published Bong Appetit cookbook, and a sought-after expert on the cannabis industry. […]

by

Zelda Therapeutics has engaged international experts to advise it on three experimental clinical trials it kicked off in humans over the past two years. The medicinal cannabis drug developer (ASX:ZLD) launched clinical trials in patients with insomnia and opioid dependence last year, and undertook an observational study in Chilean children with autism in 2017. It […]

by

Up Cannabis, a subsidiary of Newstrike Brands Ltd. (TSX-V: HIP), has signed a cannabis supply agreement with ZYUS Life Sciences. Under the agreement, Up Cannabis will supply dried bulk cannabis to ZYUS as raw material for processing into its cannabinoid-based products. ZYUS expects to receive licensing under the Cannabis Act and the Controlled Drugs and […]

by

Management and Board of Directors Viridium’s board of directors is now comprised of five existing Viridium directors (Jay Garnett, Harry McWatters, Sean MacNeil, Benjamin Eastwood and Dan Echino) and two former EFX directors (Michael Kohut and Michael Black). In order to accommodate the new board members, Viridium wishes to thank Jarrett Malnarick and Gary Purewal, […]

by

PITTSBURGH (PRWEB) February 11, 2019 Compassionate Certification Centers™, a U.S. medical cannabis healthcare system, today announced it plans to expand research endeavors to include more hemp-derived cannabidiol (CBD) studies following the legalization of hemp under the 2018 U.S. Farm Bill. Dr. Bryan Doner, co-founder and Chief Medical Officer at Compassionate Certification Centers, is currently leading… […]

by

SAN JUAN, Puerto Rico, Feb. 11, 2019 (GLOBE NEWSWIRE) — Veritas Pharma Puerto Rico, Inc., a wholly owned subsidiary of Veritas Pharma, Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) (“Veritas”), in partnership with the Institute for Medical Cannabis (“IMC”) and the Fundación de Investigación (“FDI”) were approved this past Friday for an Investigation License […]

by

Wealthtrust Axiom Llc increased its stake in Tetra Technologies Inc Del (TTI) by 34.15% based on its latest 2018Q3 regulatory filing with the SEC. Wealthtrust Axiom Llc bought 161,150 shares as the company’s stock declined 54.99% with the market. The institutional investor held 633,070 shares of the energy company at the end of 2018Q3, valued […]

by

ALGAE TEC LTD/S (OTCMKTS:ALGXY) and Geovax Labs (OTCMKTS:GOVX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, valuation, dividends, analyst recommendations, earnings and institutional ownership. Profitability This table compares ALGAE TEC LTD/S and Geovax Labs’ net margins, return on […]

by

Cannabidiol, or CBD, has become a household name. On many social media sites, people suggest “but have you tried CBD oil?” on posts pertaining to any health-related issue. CBD, a minor constituent of marijuana, is widely touted as nature’s miracle by CBD enthusiasts. It does not get people high, unlike marijuana’s main constituent, delta-9-tetrahydrocannabinol (THC). […]

by

Analysts expect Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) to report $-0.13 EPS on February, 11.After having $-0.18 EPS previously, Cyclacel Pharmaceuticals, Inc.’s analysts see -27.78 % EPS growth. The stock decreased 1.20% or $0.01 during the last trading session, reaching $0.82. About 33,286 shares traded. Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) has declined 54.10% since February 10, 2018 and […]

by